Genomic and proteomic analysis of patient tumors for molecular target selection.

被引：0
|
作者：
Andrali, Shiva Sreenath
Gordon, Erlinda Maria
Reddy, Sandeep K.
Sellappan, Shankar
Chang, John
Sachdev, Esha
Chawla, Sant P.
机构：
[1] Sarcoma Oncol Res Ctr, Santa Monica, CA USA
[2] Sarcoma Oncol Ctr, Santa Monica, CA USA
[3] NantOmics LLC, Santa Cruz, CA USA
[4] NantOmics LLC, Rockville, MD USA
[5] Cedar Sinai, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e23567
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23567
引用
收藏
页数：1
相关论文
共 50 条
  • [31] New target discovery for oncology utilizing phenotypic selection and primary NSCLC patient tumors
    Holoweckyj, Nicholas M.
    Sandercock, Alan
    Guillard, Sandrine
    Rust, Steven
    Hay, Carl
    Brand, Erin
    Meekin, John
    Huang, Qihui
    Sachsenmeier, Kris
    Hollingsworth, Robert E.
    Minter, Ralph
    Bowden, Emma
    CANCER RESEARCH, 2012, 72
  • [32] Selection of genomic target RNAs by iterative screening
    Brunel, C
    Ehresmann, B
    Ehresmann, C
    McKeown, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (10) : 2533 - 2541
  • [33] Molecular architecture of ascidian spermatozoa: Genomic and proteomic approaches
    Inaba, Kazuo
    ZOOLOGICAL SCIENCE, 2004, 21 (12) : 1221 - 1221
  • [34] Primer: genomic and proteomic tools for the molecular dissection of disease
    Erin J Walker
    Katherine A Siminovitch
    Nature Clinical Practice Rheumatology, 2007, 3 : 580 - 589
  • [35] Primer: genomic and proteomic tools for the molecular dissection of disease
    Walker, Erin J.
    Siminovitch, Katherine A.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (10): : 580 - 589
  • [36] An optogenetic analysis of the minimal requirements for bud-site selection.
    Strickland, D.
    Glotzer, M.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [37] CLASSIFICATION AND ANALYSIS OF THE NOISE IMMUNITY OF EXTERNAL CRITERIA FOR MODEL SELECTION.
    Stepashko, V.S.
    Kocherga, Yu.L.
    1600, (17):
  • [38] Characteristics of patients beginning a newly released dmard: Expected response and patient selection.
    Wolfe, F
    Hawley, DJ
    ARTHRITIS AND RHEUMATISM, 1999, 42 (09): : S75 - S75
  • [39] Multiregion Genomic Analysis of Serially Transplanted Patient-derived Xenograft Tumors
    Sato, Kuniaki
    Niida, Atsushi
    Masuda, Takaaki
    Shimizu, Dai
    Tobo, Taro
    Kuroda, Yousuke
    Eguchi, Hidetoshi
    Nakagawa, Takashi
    Suzuki, Yutaka
    Mimori, Koshi
    CANCER GENOMICS & PROTEOMICS, 2019, 16 (01) : 21 - 27
  • [40] An approach to proteomic analysis of human tumors
    Emmert-Buck, MR
    Gillespie, JW
    Paweletz, CP
    Ornstein, DK
    Basrur, V
    Appella, E
    Wang, QH
    Huang, J
    Hu, N
    Taylor, P
    Petricoin, EF
    MOLECULAR CARCINOGENESIS, 2000, 27 (03) : 158 - 165
12345